Cite
Mendelson J, Jones RT. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?. Drug Alcohol Depend. 2003;70(2):S29-37doi: 10.1016/s0376-8716(03)00057-7.
Mendelson, J., & Jones, R. T. (2003). Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?. Drug and alcohol dependence, 70(2), S29-37. https://doi.org/10.1016/s0376-8716(03)00057-7
Mendelson, John, and Jones, Reese T. "Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?." Drug and alcohol dependence vol. 70,2 (2003): S29-37. doi: https://doi.org/10.1016/s0376-8716(03)00057-7
Mendelson J, Jones RT. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?. Drug Alcohol Depend. 2003 May 21;70(2):S29-37. doi: 10.1016/s0376-8716(03)00057-7. PMID: 12738348.
Copy
Download .nbib